Larazotide
A lab-made "leaky gut" peptide tested for celiac disease. Its big final study was stopped. It is not approved.

Not approved in the US. Its final trial was stopped in 2022.
Only the lowest dose helped. The final big trial was stopped.
Over 600 people in trials, side effects similar to placebo.
Three separate grades: the law (not approved), proof (mixed), and safety data (decent for a tested drug). Good safety data does not mean it works.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts
What is it?
Larazotide is a lab-made chain of 8 building blocks. It was made to block zonulin, a body signal that loosens the "tight junctions." Those are the seals between the cells lining your gut. It is taken by mouth and acts right in the gut.
Why do people use it?
It was built for celiac disease, where gluten hurts the gut even in people trying to avoid it. Online, people call it a "leaky gut" peptide for many other problems. Those uses have not been tested.
Does it really work?
Mixed. Across 4 trials with 626 people, it did not change the gut leak test. Symptoms got a little better in some trials, mostly at the lowest dose. The 342-person trial found the same. In 2022, the company stopped its final big trial. A 2025 study in 12 children with a rare COVID problem looked hopeful but was tiny.
Studies in people
We found 6 studies in people, all in celiac disease except one tiny study in children. None tested "leaky gut" in general.
| Study design | People | What they measured | What they found | Year | Journal | PubMed |
|---|---|---|---|---|---|---|
| Randomized, placebo, gluten challenge | 21 adults with celiac disease | Safety, gut leak, symptoms | Safe. Fewer gut symptoms than placebo. | 2007 | Aliment Pharmacol Ther | PMID 17697209 |
| Randomized, placebo, 14-day gluten challenge | 86 adults with celiac disease | Gut leak test and symptoms | Gut leak test did not differ. Lower doses limited some symptoms. | 2012 | Am J Gastroenterol | PMID 22825365 |
| Randomized, placebo, 6-week gluten challenge | 184 adults with celiac disease | Gut leak test, symptoms, immune markers | Gut leak test did not differ. The lowest dose limited symptoms. | 2013 | Aliment Pharmacol Ther | PMID 23163616 |
| Randomized, placebo, 12 weeks | 342 adults with celiac disease | Symptoms on a gluten-free diet | Only the lowest dose eased symptoms. Higher doses did not. | 2015 | Gastroenterology | PMID 25683116 |
| Review of 4 randomized trials | 626 adults with celiac disease | Gut leak test and symptoms | No change in the gut leak test. Some symptom help during gluten challenge. | 2022 | Clin Res Hepatol Gastroenterol | PMID 34339872 |
| Randomized, placebo, phase 2a | 12 children with MIS-C after COVID | Safety and recovery | No drug-related side effects. Gut symptoms cleared faster. Very small. | 2025 | Sci Transl Med | PMID 40737433 |
Trials listed on ClinicalTrials.gov
Is it safe? Side effects
- In trials of more than 600 people, side effects were about the same as placebo.
- It is not approved, so there is no FDA label.
- Products sold online are not checked by the FDA.
Is it legal in the US?
Larazotide is not FDA-approved. Its last big study was stopped early, so it is not close to approval.
What this means for Larazotide
Banned in sports? Drug tests
Not named, but may be banned.
Larazotide is not named on WADA's list. But WADA says its list is not complete. It also bans any drug that is not approved for people by any government anywhere (section S0). From Jan 1, 2027, that rule names "peptides" too. Ask USADA before you use it.
Talk to your doctor
If you have gut symptoms, ask a doctor to test for celiac disease before cutting gluten. The test works best while you still eat gluten. We never share doses or tell you where to buy. Print our doctor questions sheet.
More questions
What is larazotide used for?
It was tested for celiac disease symptoms in people already on a gluten-free diet. It is not approved.
Is larazotide a GLP-1?
No. It was made to act on the seals between gut cells.
Is larazotide FDA approved?
No.
Related peptides
- KPVNot approved · Proof: Animal or lab only
- BPC-157Not approved · Proof: Early
- VIP (vasoactive intestinal peptide)Not approved · Proof: Tested: no clear benefit
Guides and tools
- Peptides for gut health: what really works?Guide
- Drug test & sports ban checkerTool
- Compare Larazotide with another peptideTool
- Is my peptide source legit?Tool
- FDA warning letters trackerTool